Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study - Coleman, RL; Lorusso, D; Gennigens, C; innovaTV 204/GOG-3023/ENGOT-cx6 Collaborators (Lancet Oncol, 2021)